GLP-1 & Weight Loss
Our GLP-1 & Weight Loss category includes the most studied metabolic research peptides available in Canada. Products include semaglutide, tirzepatide, retatrutide, cagrilintide, mazdutide, survodutide, AOD9604, and 5-amino-1mq. These compounds are studied for their roles in glucagon-like peptide signalling, appetite regulation, and metabolic research. All products are lab-tested for purity and shipped fast across Canada from EhBuddy Peptides.
Semaglutide
EhBuddy Research-Grade Semaglutide — Available in 5mg, 10mg, 15mg, 20mg, 30mg
Semaglutide is the world's most studied GLP-1 receptor agonist, forming the backbone of modern metabolic, obesity, and cardiovascular research. SUSTAIN and STEP trial data demonstrate profound reductions in body weight (up to 17.4%), HbA1c, and MACE events, establishing Semaglutide as the gold standard reference compound for GLP-1 research.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
Tirzepatide
Retatrutide
1-bioglutide
EhBuddy Research-Grade 1-bioglutide — Available in 5mg, 10mg
1-bioglutide (NA-931) is a novel investigational multi-agonist studied as a “GLP-4” quadruple agonist for metabolic and weight-regulation research.
Reconstitution: Sterile or Bacteriostatic Water (BAC Water) required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only.
Cagrilintide
EhBuddy Research-Grade Cagrilintide — Available in 10mg, 5mg
Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk, studied in combination with Semaglutide (CagriSema) for obesity research. Amylin receptor activation synergizes with GLP-1 pathways to drive satiety, reduce caloric intake, and improve body composition. Phase 3 REDEFINE trials show body weight reductions potentially exceeding 25%.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
Cagrilintide & Semaglutide Blend
EhBuddy Research-Grade Cagrilintide & Semaglutide Blend — Available in 5mg, 10mg, 20mg
This blend pairs Cagrilintide (a long-acting amylin analogue) with Semaglutide (a GLP-1 receptor agonist) — the “CagriSema” combination studied for dual-pathway weight regulation.
Reconstitution: Sterile or Bacteriostatic Water (BAC Water) required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only.
Retatrutide & Cagrilintide Blend
EhBuddy Research-Grade Retatrutide & Cagrilintide Blend — Available in 10mg, 20mg
This blend pairs Retatrutide (a GLP-1/GIP/glucagon triple agonist) with Cagrilintide (an amylin analogue) for multi-pathway metabolic research.
Reconstitution: Sterile or Bacteriostatic Water (BAC Water) required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only.
Brenipatide
EhBuddy Research-Grade Brenipatide — 10mg per vial
Brenipatide is a novel long-acting incretin receptor agonist studied for metabolic and weight-regulation research.
Reconstitution: Sterile Water or Bacteriostatic Water (BAC Water) required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only.
AOD9604
EhBuddy Research-Grade AOD9604 — Available in 5 mg per vial (10 vials)
AOD9604 is the C-terminal fragment of HGH (amino acids 177-191) responsible for GH's fat-burning properties, without the growth-promoting or diabetogenic effects of full GH. Research demonstrates selective fat oxidation, lipolysis stimulation, and inhibition of lipogenesis — making AOD9604 the most targeted fat loss peptide for metabolic research, with an excellent safety profile.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only.
5-amino-1mq
Mazdutide
EhBuddy Research-Grade Mazdutide — Available in 5mg, 10mg
Mazdutide (IBI362) is a novel dual GLP-1/glucagon receptor agonist under active clinical investigation for obesity and type 2 diabetes. Phase 2 research data demonstrates exceptional body weight reduction and glycaemic improvements, combining the appetite-suppressing power of GLP-1 with glucagon's thermogenic and lipolytic effects.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
Survodutide
EhBuddy Research-Grade Survodutide
Survodutide (BI 456906) is an investigational dual GLP-1/glucagon receptor agonist in Phase 3 trials for obesity and NASH. Research data from the LIGHT UP trials demonstrates substantial body weight reduction along with significant improvements in liver histology — making it one of the most promising compounds in NASH research alongside metabolic syndrome.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
